Clinical Insight for Your Entire Organization

Access disease-level, longitudinal, oncology patient data to inform life science research, development, and commercial strategies with Vantage.

Use Cases

Make Better Decisions Across Therapy Lifecycle

From R&D to post marketing and HEOR, Vantage helps oncology biopharma teams identify opportunities and create enterprise level strategies for specific cancer diagnoses.

Inform R&D strategy, optimize trial design, or create an ECA to support regulatory submission.
Commercial and Post-Marketing

Conduct Phase IV and HEOR studies and optimize commercial strategy.

Group 125
Group 134

COTA by the Numbers

2.1M+ Cancer Patient Lives

50/50 Academic vs. Community Treatment Setting

3 Approvals Supported

9 Hematology and Solid Tumor Diagnoses

5-Year Average Follow-up

2X Higher Inclusion Percentage in ECA vs. Competitor

Quality Real-World Data for Hematologic and Solid Tumor Diagnoses

COTA’s database of patients includes longitudinal treatment and outcomes data for oncology patients including:


Solid Tumors:

Group 127
Group 161 (1)
Additional Support

Get the Most of Your Vantage Data with Real-World Insights and Support

Group 133

Fueling the Future of Cancer Research

Explore our collection of clinical research, recent press, podcasts, and more.

Group 134 (1)

RWD and GenAI: How technology’s new power couple will revolutionize life sciences

Generative AI (GenAI) is quickly proving itself to be one of the most transformative technologies of our time with its...

COTA and Texas Oncology Collaborate to Advance AI-Enabled Precision Medicine

New York — COTA, Inc., in collaboration with Texas Oncology’s Precision Health Informatics, LLC (PHI), announces an innovative collaboration aimed at...

Who, what, when…and especially where: Why care settings matter for representative real-world datasets

A vast majority of cancer patients’ care starts with a visit to a primary care provider for a routine screening...

Get a Better View with Vantage

Discover the power of real-world cancer data for your life science organization.